Viewing StudyNCT00159250



Ignite Creation Date: 2024-05-05 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00159250
Status: COMPLETED
Last Update Posted: 2019-12-05
First Post: 2005-09-08

Brief Title: Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
Sponsor: Imperial College London
Organization: Imperial College London

Organization Data

Organization: Imperial College London
Class: OTHER
Study ID: 05MRE1232
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Imperial College London
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Sarepta Therapeutics Inc INDUSTRY
Department of Health United Kingdom OTHER_GOV